Characterization of leukotrienes in a pilot study of older asthma subjects

Immunity and Ageing

Volumn 7, Issue , 2010, Pages

  Nyenhuis, Sharmilee M ^a,b   Schwantes, Elizabeth A ^a   Mathur, Sameer K ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LEUKOTRIENE B4; PEPTIDOLEUKOTRIENE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; EOSINOPHIL COUNT; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MORBIDITY; MORTALITY; NEUTROPHIL COUNT; PRIORITY JOURNAL; SPUTUM ANALYSIS;

EID: 77955168440     PISSN: 17424933     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-4933-7-8     Document Type: Article

References (26)

1. National Asthma Education and Prevention Program Expert panel report 3: (Source Document) 2007, Bethesda, MD: National Heart, Lung and Blood Institute, National Asthma Education and Prevention Program., http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm
2. Busse W, Kraft M. Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest 2005, 127(4):1312-26. 10.1378/chest.127.4.1312, 15821210.
3. Enright PL, et al. Underdiagnosis and Undertreatment of Asthma in the Elderly. Chest 1999, 116(3):603-613. 10.1378/chest.116.3.603, 10492260.
4. Bellia V, et al. Asthma in the elderly - Mortality rate and associated risk factors for mortality. Chest 2007, 132(4):1175-1182. 10.1378/chest.06-2824, 17890479.
5. Quadrelli SA, Roncoroni AM. Features of asthma in the elderly. Journal of Asthma 2001, 38(5):377-389. 10.1081/JAS-100000259, 11515974.
6. Marks GB, Correll PK, Williamson M. Asthma in Australia 2005. Medical Journal of Australia 2005, 183(9):445-446.
7. Banerji A, et al. Prospective multicenter study of acute asthma in younger versus older adults presenting to the emergency department. Journal of the American Geriatrics Society 2006, 54(1):48-55. 10.1111/j.1532-5415.2005.00563.x, 16420197.
8. Oguzulgen IK, et al. What can predict the exacerbation severity in asthma?. Allergy and Asthma Proceedings 2007, 28(3):344-347. 10.2500/aap.2007.28.2949, 17619565.
9. Moorman JERR, Johnson CA, et al. National Surveillance for Asthma --- United States, 1980--2004. MMWR Surveillance Summary 2007, 56(8):1-54.
10. Busse WW. Leukotrienes and inflammation. American Journal of Respiratory and Critical Care Medicine 1998, 157(6):S210-S213.
11. Nagata M, Sedgwick JB, Busse WW. Differential-Effects of Granulocyte-Macrophage Colony-Stimulating Factor on Eosinophil and Neutrophil Superoxide Anion Generation. Journal of Immunology 1995, 155(10):4948-4954.
12. Hamid Q, et al. Inflammatory cells in asthma: Mechanisms and implications for therapy. Journal of Allergy and Clinical Immunology 2003, 111(1, Supplement 1):S5-S17. 10.1067/mai.2003.22, 12532083.
13. Pavord ID, et al. Induced Sputum Eicosanoid Concentrations in Asthma. Am J Respir Crit Care Med 1999, 160(6):1905-1909.
14. Mathur SK, et al. Age-Related Changes in Eosinophil Function in Human Subjects. Chest 2008, 133(2):412-419. 10.1378/chest.07-2114, 18252914.
15. Gern JE, et al. Relationship of Upper and Lower Airway Cytokines to Outcome of Experimental Rhinovirus Infection. American Journal of Respiratory and Critical Care Medicine 2000, 162(6):2226-2231.
16. Yamamoto H, Sedgwick JB, Busse WW. Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. Journal of Immunology 1998, 161(2):971-977.
17. Sears MR, et al. A Longitudinal, Population-Based, Cohort Study of Childhood Asthma Followed to Adulthood. The New England Journal of Medicine 2003, 349(15):1414-1422. 10.1056/NEJMoa022363, 14534334.
18. Nyenhuis SM, et al. Airway neutrophil inflammatory phenotype in older subjects with asthma. The Journal of allergy and clinical immunology 125(5):1163-1165. 10.1016/j.jaci.2010.02.015, 20381851.
19. Fulop T, et al. Signal transduction and functional changes in neutrophils with aging. Aging Cell 2004, 3(4):217-226. 10.1111/j.1474-9728.2004.00110.x, 15268755.
20. Fortin CF, et al. GM-CSF activates the Jak/STAT pathway to rescue polymorphonuclear neutrophils from spontaneous apoptosis in young but not elderly individuals. Biogerontology 2007, 8(2):173-187. 10.1007/s10522-006-9067-1, 17086367.
21. Wenzel SE. The role of leukotrienes in asthma. Prostaglandins, Leukotrienes and Essential Fatty Acids 2003, 69(2-3):145-155.
22. Schleimer RP, et al. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. Journal of Pharmacology And Experimental Therapeutics 1989, 250(2):598-605.
23. Steiss JO, et al. Effect of inhaled corticosteroid treatment on exhaled breath condensate leukotriene E-4 in children with mild asthma. Allergy and Asthma Proceedings 2008, 29(4):371-375. 10.2500/aap.2008.29.3135, 18702883.
24. Creticos P, et al. Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age. Annals of Allergy Asthma & Immunology 2002, 88(4):401-409.
25. Korenblat PE, et al. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT). Annals of Allergy Asthma & Immunology 2000, 84(2):217-225.
26. Wenzel SE. Asthma: defining of the persistent adult phenotypes. The Lancet 2006, 368(9537):804-813.